# Swertiamarin (Iridoid Glycoside)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/swertiamarin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Swertiamarin, Enicostemma littorale glycoside, Gentiana macrophylla extract, Qinjiao compound, Indian gentian iridoid, Mamajjaka extract, Felwort glycoside

## Overview

Swertiamarin is an iridoid glycoside compound found in Swertia species that demonstrates anti-inflammatory properties through inhibition of [pro-inflammatory cytokine](/ingredients/condition/inflammation)s including TNF-α, IL-1β, IL-6, and IL-8. This bioactive compound also supports [immune function](/ingredients/condition/immune-support) by enhancing antibody production and promoting Th2 immune responses.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects through inhibition of TNF-α, IL-1β, IL-6, and IL-8 cytokines (preliminary evidence from animal studies)
• [Immunomodulat](/ingredients/condition/immune-support)ion support by increasing antibody titers and enhancing Th2 responses (shown in rat SRBC models at 2-10 mg/kg)
• Intestinal healing promotion via stem cell proliferation in ulcerative colitis (demonstrated in DSS-induced colitis mice)
• Blood sugar regulation with reduced glucose and HbA1c levels (observed in diabetic rat models at 15-50 mg/kg)
• Antifibrotic activity by reducing TGF-β1 and hepatic stellate cell activation (preliminary mechanistic studies)

## Mechanism of Action

Swertiamarin inhibits nuclear factor-kappa B (NF-κB) signaling pathways, reducing production of [inflammatory](/ingredients/condition/inflammation) cytokines TNF-α, IL-1β, IL-6, and IL-8. The compound enhances humoral [immunity](/ingredients/condition/immune-support) by increasing antibody titers and shifting immune responses toward Th2-mediated pathways. It also promotes intestinal healing through stimulation of intestinal stem cell activity and epithelial regeneration.

## Clinical Summary

Current evidence for swertiamarin comes primarily from animal studies, with limited human clinical data available. Rat studies using sheep red blood cell (SRBC) models showed enhanced antibody production at doses of 2-10 mg/kg body weight. [Anti-inflammatory](/ingredients/condition/inflammation) effects have been demonstrated in various rodent models of inflammation and tissue injury. However, well-controlled human clinical trials are needed to establish therapeutic efficacy and optimal dosing protocols in humans.

## Nutritional Profile

Swertiamarin is a pure isolated iridoid glycoside compound (C16H22O10, MW: 374.34 g/mol), not a whole food ingredient, and therefore contains no macronutrients (zero protein, fat, or carbohydrate in the dietary sense), no vitamins, and no minerals in its isolated form. As a bioactive phytochemical, its profile is defined entirely by its chemical structure and pharmacological activity rather than nutritional content. It is the predominant bitter iridoid glycoside found in Swertia chirata (chirayata) and related Gentianaceae family plants, typically constituting 1–3% dry weight of Swertia chirata herb and up to 5–7% in some Enicostemma species. The compound consists of a secologanin-derived aglycone (erythrocentaurin precursor) linked to a glucose moiety via a β-glycosidic bond. Upon hydrolysis in the gut, it releases swertiamarin aglycone and glucose. Bioavailability is considered moderate; the glycoside form undergoes intestinal bacterial hydrolysis and hepatic first-pass [metabolism](/ingredients/condition/weight-management), with peak plasma concentrations observed at approximately 1–2 hours post-oral administration in rodent models. Effective experimental doses range from 2–50 mg/kg body weight in animal studies; no established human RDA or DRI exists. No fiber, protein, lipid, or micronutrient content is applicable to this isolated compound.

## Dosage & Preparation

No human dosages have been established. Animal studies used: 2-10 mg/kg orally for [immunomodulat](/ingredients/condition/immune-support)ion (7 days), 15-50 mg/kg orally for antidiabetic effects (28 days), and 100-200 mg/kg orally for analgesia in mice. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for swertiamarin in humans is limited due to lack of comprehensive clinical studies. No specific drug interactions have been documented, though potential interactions with immunosuppressive medications may occur given its [immunomodulat](/ingredients/condition/immune-support)ing properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use, as immune system enhancement could potentially exacerbate certain autoimmune disorders.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses on swertiamarin have been conducted; all available evidence comes from preclinical animal models and in vitro studies. Research includes [immunomodulat](/ingredients/condition/immune-support)ion studies in rats, ulcerative colitis models in mice, and antidiabetic effects in streptozotocin-induced diabetic rats, though specific PMIDs were not provided in the source material.

## Historical & Cultural Context

Swertiamarin-containing plants have been used for centuries in traditional Chinese medicine, where Gentiana macrophylla (Qinjiao) treats [inflammatory](/ingredients/condition/inflammation) conditions, rheumatic pain, and digestive disorders. In Ayurvedic tradition, Enicostemma littorale has been employed for diabetes, liver issues, and fever management.

## Synergistic Combinations

Gentiopicroside, Sweroside, (R)-gentiandiol, Curcumin, Quercetin

## Frequently Asked Questions

### What is the effective dosage of swertiamarin for anti-inflammatory effects?

Animal studies suggest doses of 2-10 mg/kg body weight show immunomodulating effects, but human clinical data is lacking. No standardized dosing recommendations exist for humans currently.

### Which plants contain swertiamarin naturally?

Swertiamarin is primarily found in Swertia species, including Swertia chirayita and Swertia japonica. These bitter herbs have been used traditionally in Asian medicine systems for digestive and inflammatory conditions.

### Can swertiamarin help with inflammatory bowel conditions?

Preliminary animal research suggests swertiamarin may promote intestinal healing through stem cell stimulation and anti-inflammatory effects. However, human studies are needed to confirm efficacy for inflammatory bowel conditions.

### Does swertiamarin interact with immune system medications?

While no specific interactions are documented, swertiamarin's immunomodulating properties could theoretically interact with immunosuppressive drugs. Patients on immune-modifying medications should consult healthcare providers before use.

### How long does it take for swertiamarin to show anti-inflammatory effects?

Based on animal studies, immune system changes were observed within days to weeks of administration. However, the timeline for anti-inflammatory benefits in humans remains unknown due to limited clinical research.

### Is swertiamarin safe for children or elderly individuals?

Current safety data on swertiamarin in children and elderly populations is limited, as most research has been conducted in animal models rather than human clinical trials. While swertiamarin is derived from traditionally used plants with long ethnobotanical histories, specific pediatric and geriatric safety profiles have not been established. Consultation with a healthcare provider is recommended before giving swertiamarin supplements to children or elderly individuals, particularly those with existing health conditions or taking multiple medications.

### What is the difference between swertiamarin and other iridoid glycosides in terms of bioactivity?

Swertiamarin is distinguished from other iridoid glycosides by its specific ability to inhibit multiple pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8) simultaneously and its documented effects on Th2 immune response enhancement in animal models. While other iridoid glycosides share anti-inflammatory properties, swertiamarin demonstrates particular efficacy in intestinal epithelial healing through stem cell proliferation pathways. The potency and mechanism of action can vary significantly between different iridoid glycosides, making swertiamarin notable for its multi-target inflammatory signaling effects.

### How strong is the current clinical evidence for swertiamarin's effectiveness in humans?

The evidence for swertiamarin's effectiveness is currently limited to preliminary animal studies, including rat SRBC immunization models and DSS-induced colitis mouse models, with no published human clinical trials yet available. While these preclinical findings show promise for anti-inflammatory and immunomodulatory effects, the translation from animal models to human efficacy remains unproven. More rigorous human clinical trials are needed to establish safe and effective dosing, confirm mechanism of action in humans, and determine its therapeutic potential for inflammatory conditions.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*